White label – Pompe disease - ClinicalTrials.eu

Study on Surgery with or without Darolutamide for Patients with High-Risk or Locally Advanced Prostate Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
- Darolutamide
Study on Overactive Bladder Treatment for Women Using Clostridium Botulinum Neurotoxin Type A and Vibe System

Not recruiting

2 1 1
Investigated Diseases:
- Hypertonic bladder
Investigated Drugs:
- Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
Study on Reducing Bleeding by Omitting Aspirin in Patients with Non-ST Elevation Acute Coronary Syndrome

Not recruiting

3 1 1 1
Investigated Diseases:
- Acute coronary syndrome
Investigated Drugs:
- Acetylsalicylic Acid
Study on the Safety of Ceftolozane and Tazobactam for Children with Hospital-Acquired Pneumonia

Not recruiting

1 1 1 1
Investigated Diseases:
- Pneumonia
Investigated Drugs:
- Ceftolozane
- Tazobactam
Study on Long-term Safety of Ustekinumab for Children with Crohn’s Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Ustekinumab
+1
Study Comparing Bictegravir and Lenacapavir to Current Treatment in Patients with HIV-1 on Complex Regimens

Not recruiting

4 1 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
Study on Peppermint Oil and Caraway Oil for Patients with Functional Gastrointestinal Disorders

Not recruiting

3 1 1 1
Investigated Diseases:
- Functional gastrointestinal disorder
Investigated Drugs:
- Caraway Oil
- Peppermint Oil
Study on Ribociclib with Hormone Therapy and Radiotherapy for Elderly Patients with Newly Diagnosed Breast Cancer with Positive Hormone Receptors and Negative HER2 Status

Not recruiting

1 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
- Ribociclib
Study on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain

Not recruiting

3 1 1
Investigated Diseases:
- Back pain
Investigated Drugs:
Study Comparing Subcutaneous Pembrolizumab with Hyaluronidase to Intravenous Pembrolizumab and Chemotherapy for First-line Treatment of Metastatic Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies